Skip to main content

Paragon 28, Inc. (FNA) Stock Forecast 2025 - AI Price Prediction & Analysis


Paragon 28, Inc. (FNA) AI Stock Price Forecast & Investment Analysis

Paragon 28, Inc. Stock Price Chart and Technical Analysis

Loading Paragon 28, Inc. interactive price chart and technical analysis...

Paragon 28, Inc. (FNA) - Comprehensive Stock Analysis & Investment Research

Deep dive into Paragon 28, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Paragon 28, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Paragon 28, Inc.: Paragon 28, Inc. operates in the Industrial Applications and Services sector, making it an emerging small-cap investment.

Paragon 28, Inc. (Stock Symbol: FNA) is a leading company in the Industrial Applications and Services sector , specifically operating within the Surgical & Medical Instruments & Apparatus industry.

The organization employs approximately 625 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Paragon 28, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Paragon 28, Inc.: With $235M in annual revenue and -24.2% net margin, the company demonstrates developing profitability.

Annual Revenue: $235 million generating a -24.2% net profit margin .

Market Capitalization: $1098 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -11.9% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Paragon 28, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For Paragon 28, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Paragon 28, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Paragon 28, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Paragon 28, Inc.: Market positioning analysis based on available financial and operational metrics.

Paragon 28, Inc. strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 77.4% gross margin, indicating strong pricing power and operational efficiency.

Paragon 28, Inc. (FNA) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Paragon 28, Inc. stock analysis.

Loading Paragon 28, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into Paragon 28, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Paragon 28, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Paragon 28, Inc.: With a P/E ratio of -15.40, the market sees the stock as potentially undervalued.

P/E Ratio -15.40x
P/B Ratio 8.41x
Market Cap $1098M
EPS $-0.74
Book Value/Share $1.56
Revenue/Share $2.82
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Paragon 28, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Paragon 28, Inc.: An ROE of -11.9% indicates room for improvement in shareholder value creation.

ROE -11.9%
ROA -8.2%
ROIC -9.0%
Gross Margin 77.4%
Operating Margin -18.6%
Net Margin -24.2%
EBT Margin -14.0%
Tax Rate 7.4%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Paragon 28, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Paragon 28, Inc.: A current ratio of 4.39 indicates strong liquidity.

Current Ratio 4.39x
Quick Ratio 3.17x
D/E Ratio 0.23x
Financial Leverage 1.46x
Interest Coverage -8.4x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Paragon 28, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Paragon 28, Inc.: Free cash flow of $-58M indicates cash challenges that need attention.

Operating Cash Flow $-17M
Free Cash Flow $-58M
Capital Spending $-42M
FCF/Sales -37.5%
CapEx/Sales 26.9%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Paragon 28, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Paragon 28, Inc.: An asset turnover of 0.58x suggests room for improvement in asset utilization.

Asset Turnover 0.58x
Receivables Turnover 5.6x
Inventory Turnover 0.7x
Fixed Assets Turnover 3.0x
Days Sales Outstanding 65 days
Days Inventory 556 days
Payables Period 153 days
Cash Conversion Cycle 468 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Paragon 28, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Paragon 28, Inc.: With annual revenue of $235M, Paragon 28, Inc. demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $235M
Operating Income $-43M
Net Income $-60M
R&D Expense $28M
SG&A Expense $82M
Cost of Goods Sold $53M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 63%
Cash & Short-term Investments 35%
Total Liabilities 31%
Short-term Debt 0%
Accounts Receivable 11%
Inventory 16%
Dividend & Shareholder Information
Shares Outstanding 84M
Growth Metrics (YoY)
EPS Growth -5.7%

Latest Paragon 28, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Paragon 28, Inc. (FNA) stock price and investment outlook.

Paragon 28, Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Paragon 28, Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ADGM Unlock Forecast - 30 Days FREE Trial $24M x 2.8x
AEMD Unlock Forecast - 30 Days FREE Trial $3M -0.1x 0.7x
AFIB Unlock Forecast - 30 Days FREE Trial $0M 0.0x -0.4x
ALUR Unlock Forecast - 30 Days FREE Trial $17M -0.4x -0.3x
AMIX Unlock Forecast - 30 Days FREE Trial $4M x 0.5x
ANGO Unlock Forecast - 30 Days FREE Trial $447M -1.4x 2.4x
ANIK Unlock Forecast - 30 Days FREE Trial $129M -4.3x 0.9x
AORT Unlock Forecast - 30 Days FREE Trial $1831M -198.2x 4.4x
APYX Unlock Forecast - 30 Days FREE Trial $76M -3.5x 10.5x
ARAY Unlock Forecast - 30 Days FREE Trial $138M -9.9x 2.8x
ATEC Unlock Forecast - 30 Days FREE Trial $2324M -7.4x 97.8x
ATRC Unlock Forecast - 30 Days FREE Trial $1750M -39.6x 3.8x
AVGR Unlock Forecast - 30 Days FREE Trial $2M -1.3x 0.4x
AVHHL Unlock Forecast - 30 Days FREE Trial $24M x x
BAX Unlock Forecast - 30 Days FREE Trial $12280M -94.9x 1.7x
BBNX Unlock Forecast - 30 Days FREE Trial $1081M x 3.6x
BDX Unlock Forecast - 30 Days FREE Trial $54398M 34.3x 2.1x
BEAT Unlock Forecast - 30 Days FREE Trial $46M -5.7x 11.0x
BEATW Unlock Forecast - 30 Days FREE Trial $15M x 3.2x
BJDX Unlock Forecast - 30 Days FREE Trial $2M -0.5x 0.4x
BLAC Unlock Forecast - 30 Days FREE Trial $12M x -2.1x
BLACR Unlock Forecast - 30 Days FREE Trial $1M x -0.2x
BLACU Unlock Forecast - 30 Days FREE Trial $14M x -2.4x
BLACW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
BSX Unlock Forecast - 30 Days FREE Trial $157140M 62.7x 7.0x
BTCY Unlock Forecast - 30 Days FREE Trial $10M -2.7x -0.1x
BVS Unlock Forecast - 30 Days FREE Trial $617M -18.3x 3.8x
CARL Unlock Forecast - 30 Days FREE Trial $-18M x x
CERS Unlock Forecast - 30 Days FREE Trial $235M -13.8x 4.2x
CLPT Unlock Forecast - 30 Days FREE Trial $314M -23.5x 15.9x
CODX Unlock Forecast - 30 Days FREE Trial $11M -0.7x 0.3x
CTCX Unlock Forecast - 30 Days FREE Trial $5M -0.2x -1.2x
CTCXW Unlock Forecast - 30 Days FREE Trial $1M x -0.2x
CTSO Unlock Forecast - 30 Days FREE Trial $64M -1.8x 4.4x
CVRX Unlock Forecast - 30 Days FREE Trial $208M -5.5x 3.6x
DCTH Unlock Forecast - 30 Days FREE Trial $465M 208.2x 4.4x
DHAI Unlock Forecast - 30 Days FREE Trial $10M x -0.3x
DHAIW Unlock Forecast - 30 Days FREE Trial $1M x 0.0x
DRIO Unlock Forecast - 30 Days FREE Trial $30M 0.6x 0.4x
DRTS Unlock Forecast - 30 Days FREE Trial $306M x 3.5x
DXCM Unlock Forecast - 30 Days FREE Trial $30993M 54.2x 12.0x
EBRCZ Unlock Forecast - 30 Days FREE Trial $246M x 5.0x
EMBC Unlock Forecast - 30 Days FREE Trial $572M 15.8x -0.8x
FEMY Unlock Forecast - 30 Days FREE Trial $12M -1.4x 8.1x
FNA Unlock Forecast - 30 Days FREE Trial $1098M -15.4x 8.4x
FOFA Unlock Forecast - 30 Days FREE Trial $8M x 13.6x
GCTK Unlock Forecast - 30 Days FREE Trial $2M 0.9x -0.5x
GIPL Unlock Forecast - 30 Days FREE Trial $5M x 27.9x
GKOS Unlock Forecast - 30 Days FREE Trial $5205M -46.3x 6.8x
GMED Unlock Forecast - 30 Days FREE Trial $8161M 22.9x 1.9x
GUTS Unlock Forecast - 30 Days FREE Trial $88M x 13.8x
HAE Unlock Forecast - 30 Days FREE Trial $3541M 26.1x 4.3x
HRGN Unlock Forecast - 30 Days FREE Trial $28M x 36.7x
IART Unlock Forecast - 30 Days FREE Trial $1179M 200.2x 1.1x
ICAD Unlock Forecast - 30 Days FREE Trial $106M -3.1x 3.5x
ICCM Unlock Forecast - 30 Days FREE Trial $60M x 20.9x
ICU Unlock Forecast - 30 Days FREE Trial $8M -1.1x 13.3x
ICUCW Unlock Forecast - 30 Days FREE Trial $0M x -0.1x
ICUI Unlock Forecast - 30 Days FREE Trial $3248M -49.8x 1.6x
IDXG Unlock Forecast - 30 Days FREE Trial $22M 4.2x -0.9x
IINN Unlock Forecast - 30 Days FREE Trial $30M x 6.8x
IINNW Unlock Forecast - 30 Days FREE Trial $8M x 2.0x
INBS Unlock Forecast - 30 Days FREE Trial $11M -0.3x 3.6x
INFU Unlock Forecast - 30 Days FREE Trial $216M 42.6x 4.0x
INSP Unlock Forecast - 30 Days FREE Trial $2323M 43.7x 3.4x
IRMD Unlock Forecast - 30 Days FREE Trial $924M 44.7x 9.8x
IRTC Unlock Forecast - 30 Days FREE Trial $5984M -20.2x 57.7x
IVF Unlock Forecast - 30 Days FREE Trial $1M x 0.3x
KIDS Unlock Forecast - 30 Days FREE Trial $488M -20.7x 1.4x
KMTS Unlock Forecast - 30 Days FREE Trial $873M x x
KRMD Unlock Forecast - 30 Days FREE Trial $188M -19.8x 11.4x
LMAT Unlock Forecast - 30 Days FREE Trial $0M 58.7x 0.0x
LNSR Unlock Forecast - 30 Days FREE Trial $58M -6.7x -7.0x
LUCD Unlock Forecast - 30 Days FREE Trial $140M -0.6x 17.7x
LUNG Unlock Forecast - 30 Days FREE Trial $71M -4.3x 1.0x
LYRA Unlock Forecast - 30 Days FREE Trial $524M -0.1x 135.2x
MBOT Unlock Forecast - 30 Days FREE Trial $92M -1.3x 3.2x
MCAG Unlock Forecast - 30 Days FREE Trial $22M x -9.6x
MCAGU Unlock Forecast - 30 Days FREE Trial $21M x -9.9x
MDAI Unlock Forecast - 30 Days FREE Trial $69M -1.3x -42.3x
MDAIW Unlock Forecast - 30 Days FREE Trial $9M x -2.1x
MDNC Unlock Forecast - 30 Days FREE Trial $59M 26.8x 13.4x
MDXG Unlock Forecast - 30 Days FREE Trial $1030M 32.0x 4.8x
MGRM Unlock Forecast - 30 Days FREE Trial $206M -10.7x 23.9x
MHUA Unlock Forecast - 30 Days FREE Trial $11M x 0.1x
MMM Unlock Forecast - 30 Days FREE Trial $84761M 21.5x 19.8x
MMSI Unlock Forecast - 30 Days FREE Trial $5586M 46.9x 3.8x
MODD Unlock Forecast - 30 Days FREE Trial $38M -2.1x 2.2x
NARI Unlock Forecast - 30 Days FREE Trial $4677M -51.9x 10.8x
NAYA Unlock Forecast - 30 Days FREE Trial $2M -0.3x 0.2x
NEPH Unlock Forecast - 30 Days FREE Trial $39M -20.3x 2.0x
NMTC Unlock Forecast - 30 Days FREE Trial $40M -1.7x 4.8x
NPCE Unlock Forecast - 30 Days FREE Trial $322M -10.4x 16.5x
NSPR Unlock Forecast - 30 Days FREE Trial $122M -4.3x 6.0x
NURO Unlock Forecast - 30 Days FREE Trial $9M -0.5x 0.7x
NVAC Unlock Forecast - 30 Days FREE Trial $69M 84.3x -13.6x
NVACR Unlock Forecast - 30 Days FREE Trial $1M x -0.1x
NVACW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
NVCR Unlock Forecast - 30 Days FREE Trial $1344M -20.8x 3.9x
NVNO Unlock Forecast - 30 Days FREE Trial $87M -2.0x 2.3x
NVRO Unlock Forecast - 30 Days FREE Trial $221M -2.1x 1.0x
NXGL Unlock Forecast - 30 Days FREE Trial $18M -6.8x 4.0x
NXGLW Unlock Forecast - 30 Days FREE Trial $3M x 0.7x
OBIO Unlock Forecast - 30 Days FREE Trial $118M -3.4x 2.0x
OFIX Unlock Forecast - 30 Days FREE Trial $580M -5.8x 1.3x
OSRH Unlock Forecast - 30 Days FREE Trial $18M x 0.2x
OSUR Unlock Forecast - 30 Days FREE Trial $241M 17.1x 0.6x
PAVM Unlock Forecast - 30 Days FREE Trial $20M 0.3x 0.5x
PAVMZ Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
PDEX Unlock Forecast - 30 Days FREE Trial $128M 14.3x 3.5x
PEN Unlock Forecast - 30 Days FREE Trial $11258M 76.2x 8.7x
PETV Unlock Forecast - 30 Days FREE Trial $18M -1.4x 12.0x
PLSE Unlock Forecast - 30 Days FREE Trial $1016M -2.6x 8.6x
PODD Unlock Forecast - 30 Days FREE Trial $23849M 101.0x 16.3x
PRCT Unlock Forecast - 30 Days FREE Trial $2128M -45.4x 5.5x
PROF Unlock Forecast - 30 Days FREE Trial $124M x 3.2x
PSTV Unlock Forecast - 30 Days FREE Trial $12M -0.3x -0.5x
PYPD Unlock Forecast - 30 Days FREE Trial $54M x 2.6x
RCEL Unlock Forecast - 30 Days FREE Trial $111M -5.0x -29.9x
RDGL Unlock Forecast - 30 Days FREE Trial $47M x 17.4x
RMD Unlock Forecast - 30 Days FREE Trial $39851M 28.5x 6.7x
RSMDF Unlock Forecast - 30 Days FREE Trial $2450M 1.8x 0.4x
RTGN Unlock Forecast - 30 Days FREE Trial $66M x x
RVP Unlock Forecast - 30 Days FREE Trial $24M -0.9x 0.3x
SGHT Unlock Forecast - 30 Days FREE Trial $192M -3.7x 2.7x
SIBN Unlock Forecast - 30 Days FREE Trial $701M -14.3x 4.1x
SINT Unlock Forecast - 30 Days FREE Trial $7M -0.5x 1.1x
SKIN Unlock Forecast - 30 Days FREE Trial $288M -1.8x 3.9x
SNOA Unlock Forecast - 30 Days FREE Trial $8M -5.6x 1.9x
SNWV Unlock Forecast - 30 Days FREE Trial $308M x -19.4x
SOLV Unlock Forecast - 30 Days FREE Trial $12464M 32.8x 3.4x
SRDX Unlock Forecast - 30 Days FREE Trial $432M -79.3x 3.9x
SRTS Unlock Forecast - 30 Days FREE Trial $53M 31.6x 1.0x
SSII Unlock Forecast - 30 Days FREE Trial $1535M x 37.9x
SSKN Unlock Forecast - 30 Days FREE Trial $7M -8.0x 24.1x
STIM Unlock Forecast - 30 Days FREE Trial $248M -1.0x 9.1x
STME Unlock Forecast - 30 Days FREE Trial $12M x x
STSS Unlock Forecast - 30 Days FREE Trial $10M -2.5x 0.7x
STSSW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
SYK Unlock Forecast - 30 Days FREE Trial $140684M 42.0x 12.0x
TCMD Unlock Forecast - 30 Days FREE Trial $319M 21.1x 1.6x
TELA Unlock Forecast - 30 Days FREE Trial $72M -1.8x 7.9x
TFX Unlock Forecast - 30 Days FREE Trial $5876M 30.6x 1.4x
TLSI Unlock Forecast - 30 Days FREE Trial $191M -3.6x -5.6x
TLSIW Unlock Forecast - 30 Days FREE Trial $66M x -1.9x
TMCI Unlock Forecast - 30 Days FREE Trial $628M -7.5x 6.0x
TNDM Unlock Forecast - 30 Days FREE Trial $835M -17.1x 6.3x
TNON Unlock Forecast - 30 Days FREE Trial $9M -0.3x 1.3x
TNONW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
TTOO Unlock Forecast - 30 Days FREE Trial $4M 0.0x -0.3x
UFPT Unlock Forecast - 30 Days FREE Trial $1757M 44.7x 4.9x
USAQ Unlock Forecast - 30 Days FREE Trial $2M x x
UTMD Unlock Forecast - 30 Days FREE Trial $208M 16.6x 1.8x
VERO Unlock Forecast - 30 Days FREE Trial $5M 0.0x 2.2x
VTAK Unlock Forecast - 30 Days FREE Trial $3M 0.0x 0.3x
VVOS Unlock Forecast - 30 Days FREE Trial $21M -0.5x 2.8x
WST Unlock Forecast - 30 Days FREE Trial $18580M 38.1x 6.3x
XAIR Unlock Forecast - 30 Days FREE Trial $303M -0.3x 22.3x
XTNT Unlock Forecast - 30 Days FREE Trial $93M -478.8x 1.9x

Frequently Asked Questions - Paragon 28, Inc. Stock Forecast

How accurate are Paragon 28, Inc. stock predictions?

Our AI model demonstrates 28% historical accuracy for FNA predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence Paragon 28, Inc. stock price forecasts?

Our analysis considers Paragon 28, Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Paragon 28, Inc. a good investment in 2025?

Based on our AI analysis, Paragon 28, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Paragon 28, Inc. forecasts updated?

Paragon 28, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Paragon 28, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Paragon 28, Inc. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...